New 2021 Forecasts Released

New Data
innovation hub

Acetylon Pharmaceuticals is Profiled in this Database

Updated At 30 Apr, 2012

Start Free 7 Day Trial Now
Partial description of this company
Selective small molecule histone deacetylase inhibitors to treat multiple myeloma with possible indications for inflammatory, neurodegenerative, infectious and genetic disease

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Acetylon Pharmaceuticals plus 4816 other startups.

Start Free 7 Day Trial Now

Learn More About Acetylon Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients